Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index, and 1 are not checked yet.

Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus

Open access
Davì, Giovanni, Catalano, Isabella, Averna, Maurizio, Notarbartolo, Alberto, Strano, Antonio, Ciabattoni, Giovanni, Patrono, Carlo · 1990 · New England Journal of Medicine

Abstract

It has been suggested that platelet hyperreactivity in patients with diabetes mellitus is associated with increased platelet production of thromboxane. We therefore compared the excretion of a thromboxane metabolite and platelet function in 50 patients with Type II diabetes mellitus who had normal renal function and clinical evidence of macrovascular disease and in 32 healthy controls. The mean (+/- SD) excretion rate of urinary 11-dehydro-thromboxane B2 was significantly higher in the patients than in the controls (5.94 +/- 3.68 vs. 1.50 +/- 0.79 nmol per day; P less than 0.001), irrespective of the type of macrovascular complication. Tight metabolic control achieved with insulin therapy reduced the levels of 11-dehydro-thromboxane B2 by approximately 50 percent. The fractional conversion of exogenous thromboxane B2 (infused at a rate of 4.5, 45.3, or 226.4 fmol per kilogram of body weight per second) to urinary 11-dehydro-thromboxane B2 was assessed in four patients, in whom it averaged 5.4 +/- 0.1 percent; this value did not differ from that measured in healthy subjects. Aspirin in low doses (50 mg per day for seven days) reduced urinary excretion of the metabolite by approximately 80 percent in four patients. The fact that thromboxane biosynthesis recovered over the following 10 days was consistent with a platelet origin of the urinary metabolite.(ABSTRACT TRUNCATED AT 250 WORDS)

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199006213222503

Cites

24 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Research works printed but not linked: 3

  1. Halushka, 1981, J Lab Clin Med, 97, 87
  2. Patrono C, Ciabattoni G, Patrignani P. Biochemical indices of arachidonate metabolism by platelets and vascular endothelium in vivo. In: Patrono C, FitzGerald GA, eds. Platelets and vascular occlusion. New York: Raven Press, 1989:193–212.
  3. Davì, 1989, Diabetes Res, 10, 7

Cited by

See all 634

Metadata

Authors
Davì, G., Catalano, I., Averna, M., Notarbartolo, A., Strano, A., Ciabattoni, G., & Patrono, C.
Affiliations
Università Cattolica del Sacro Cuore (IT)
Venue
New England Journal of Medicine
Published
1990-06-21
Volume
322
Issue
25
Pages
1769-1774
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1966562996
Cited by
597
References
24
Citations by year
2026: 6 · 2025: 8 · 2024: 6 · 2023: 5 · 2022: 12 · 2021: 12 · 2020: 11 · 2019: 15 · 2018: 14 · 2017: 13 · 2016: 14 · 2015: 19 · 2014: 13 · 2013: 22 · 2012: 28
FWCI
8.96
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords
thromboxane synthesis, platelet function, type 2 diabetes, platelet hyperreactivity, urinary 11-dehydrothromboxane B2, thromboxane B2, macroangiopathy, insulin therapy, aspirin
MeSH terms
Adult, Aged, Aged, 80 and over, Aspirin, Blood Platelets, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Platelet Aggregation, Thromboxane A2, Thromboxane B2, Thromboxanes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus. https://app.cochat.ai/papers/10.1056/nejm199006213222503
The paper
Davì, G., Catalano, I., Averna, M., Notarbartolo, A., Strano, A., Ciabattoni, G., & Patrono, C. (1990). Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus. New England Journal of Medicine. https://doi.org/10.1056/nejm199006213222503

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.